P/B
1,9
Anika Therapeutics
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.
$258.7M
Market Cap • 11/5/2026
1992
(34 years)
Founded
1993
(33 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
2,1
P/EBITDA
505,3
P/OCF
43,3
P/FCF
460,3
P/E
—
BVPS
10,3
EPS
—
Market Cap
Market Cap
258,7M
EV
243,6M
EV/Revenue
2
EV/EBITDA
475,8
EV/EBIT
-47,6
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
6,3%
Total Yield
6,3%
Payout
0%
Retained Earnings
59M
Profitability
Gross Margin
62,2%
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
22,8%
Capex/Revenue
4,5%
Capex/D&A
96,1%
Capex/OCF
90,6%
SBC/OCF
220%
% PPE
35,5%
% Goodwill
4,3%
ROE
—
ROIC
—
Growth
CAGR Revenue 5Y
-2,5%
CAGR Op. Income 5Y
-19,8%
CAGR Net Income 5Y
-24,5%
CAGR EPS 5Y
-28,3%
CAGR OCF 5Y
-10,3%
Leverage
N.D./EBITDA
—
Debt/Equity
0%
Current Ratio
4,5
Quick Ratio
3
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!